- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01942018
Per Oral Endoscopic Myotomy (POEM) for Esophagogastric Junction Outflow Obstruction (EGOO)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients with EGOO have difficulty swallowing and/or chest pain. Previously we were not able to distinguish this disease from achalasia. Achalasia is a disease which is characterized by a progressive difficulty with swallowing. It is caused by failure of relaxation of the lower esophageal sphincter (sphincter between esophagus and stomach) along with an essentially aperistaltic esophageal body.
However, EGOO patients have abnormal lower esophageal sphincter relaxation with some preserved peristaltic activity. Because they have some peristalsis, these patients are not diagnosed with achalasia.
Currently, a new diagnostic method, known as high-resolution manometry (HRM), can identify EGOO patients. EGOO patients usually do not respond well to medical treatment and surgery is required in most cases to reduce the pressure of lower esophageal sphincter muscles. This procedure is called "Heller myotomy".
Recently, a new endoscopic method for reducing lower esophageal sphincter pressure has been developed. This method, per-oral endoscopic myotomy (POEM) is now being performed clinically throughout the world, including Johns Hopkins Hospital. The technique utilizes a flexible endoscope to tunnel beneath the esophageal surface layer and cutting muscle fibers of the lower esophagus and upper stomach. POEM is an alternative to invasive surgery with fewer complications. POEM is performed safely at Johns Hopkins Hospital for achalasia patients. Outcomes of POEM have been excellent with greater than 90% positively responding to endoscopic myotomy. Patients with EGOO are being diagnosed more often due to increased use of HRM. They respond poorly to endoscopic therapies but well to surgical myotomy. POEM is the endoscopic equivalent to surgical intervention and represents a less invasive approach to treating these patients.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Consecutive adult patients (18-70 years of age) with symptomatic dysphagia (dysphagia score ≥2) EGOO that is diagnosed by high resolution manometry.
- Ability to give informed consent.
Exclusion Criteria:
- Unable to give informed consent
- Pregnant or breastfeeding women (all female patients if child-bearing age will undergo urine pregnancy testing prior to endoscopy)
- Acute gastrointestinal bleeding
- Coagulopathy defined by prothrombin time < 50% of control; partial thromboplastin time (PTT) > 50 sec, or international normalized ratio (INR) > 1.5), on chronic anticoagulation, or platelet count <75,000
- Inability to tolerate sedated upper endoscopy due to cardio-pulmonary instability or other contraindication to endoscopy
- Prior esophageal or gastric surgeries
- Cirrhosis with portal hypertension, varices, and/or ascites
- Active Esophagitis
- Hiatal hernia larger than 2cm
- Barrett's esophagus
- Eosinophilic esophagitis
- Esophageal stricture
- Esophageal malignancy
- Large esophageal diverticulum
- Mechanical obstruction to esophageal outflow or infiltrative esophageal or gastric disorders.
- Prior esophageal Botox injection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EGOO
Patients presenting with symptomatic gastroesophageal junction outflow obstruction (EGOO)who will be treated with Per oral endoscopic myotomy (POEM)
|
Patients will receive Per oral endoscopic myotomy (POEM) for symptomatic gastroesophageal junction outflow obstruction (EGOO)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in dysphagia severity
Time Frame: 2 and 6 months
|
Dysphagia will be measured by Dysphagia score and Eckhardt score at 2 and 6 months after the procedure (The Eckhardt score takes into consideration symptoms of dysphagia, chest pain, regurgitation and chest pain)
|
2 and 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of hospital stay
Time Frame: 2 years
|
2 years
|
|
|
Resolution in Esophago-gastric junction (EGJ) outflow obstruction by HRM performed 2 months after the procedure
Time Frame: 2 months
|
2 months
|
|
|
Change in participants' quality of life
Time Frame: 2 and 6 months
|
Improvement in patient's quality of life as reflected by Short Form-36 questionnaire at 2 and 6 months after the procedure
|
2 and 6 months
|
|
Complication rate
Time Frame: 2 years
|
Complications include any of the following (full thickness perforations, unplanned mucosectomies, immediate and delayed bleeding).
|
2 years
|
|
Procedural times
Time Frame: 2 years
|
2 years
|
|
|
Post procedural Gastroesophageal reflux disease (GERD)
Time Frame: 2 months
|
Frequency of post-procedural GERD as documented by either 24 hr ph/Impedence testing, 48 hr Bravo (performed at 2 months), or esophagogastroduodenoscopy (EGD) with evidence of esophagitis
|
2 months
|
|
Time to resume normal diet
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NA_00082967
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophagogastric Junction Outflow Obstruction
-
Baylor Research InstituteEnrolling by invitationEsophagogastric Junction Outflow Obstruction | Achalasia, Esophageal | Spastic Esophageal DisordersUnited States
-
Baylor Research InstituteActive, not recruitingEsophagogastric Junction Outflow ObstructionUnited States
-
University of Kansas Medical CenterWithdrawnEsophagogastric Junction Disorder
-
Ruijin HospitalRecruitingGastric or Esophagogastric Junction AdenocarcinomaChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingEsophagogastric Junction CarcinomaChina
-
Beijing Immunochina Medical Science & Technology...Peking University Cancer Hospital & InstituteNot yet recruitingAdenocarcinoma of Esophagogastric Junction | Adenocarcinoma of GastricChina
-
Hebei Medical University Fourth HospitalNot yet recruitingSiewert Type II Adenocarcinoma of the Esophagogastric JunctionChina
-
Wake Forest University Health SciencesWithdrawnEsophagogastric Junction DisorderUnited States
-
St. James's Hospital, IrelandUnknownBarrett Esophagus | Siewert Type II Adenocarcinoma of Esophagogastric Junction | Oesophagus Cancer | Siewert Type I Adenocarcinoma of Esophagogastric Junction | Siewert Type III Adenocarcinoma of Esophagogastric JunctionIreland
-
Guangdong Provincial Hospital of Traditional Chinese...RecruitingSiewert Type II Adenocarcinoma of Esophagogastric Junction | Esophagogastric Junction AdenocarcinomaChina
Clinical Trials on POEM
-
AdventHealthMayo Clinic; University of South FloridaCompleted
-
Shanghai Zhongshan HospitalUnknownEsophageal AchalasiaChina
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompleted
-
Shanghai Zhongshan HospitalUnknown
-
Karolinska InstitutetActive, not recruiting
-
Weill Medical College of Cornell UniversityUnknownAchalasiaUnited States
-
Shanghai Zhongshan HospitalUnknown
-
University of California, IrvineCedars-Sinai Medical Center; University of Ottawa; Hoag Memorial Hospital Presbyterian and other collaboratorsNot yet recruitingAchalasia, Esophageal | GERD (Gastroesophageal Reflux Disease)United States
-
Baylor Research InstituteTerminated
-
Shanghai Zhongshan HospitalUnknown